Table 1 Cost Analysis of Treatment.

From: New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections

  1. Note: Immune compromised not reported, assume cost similar to mothers multiplied by number of unknown cases.
  2. aaCost of medicines, manufactured in the United States, prior to August 2015.
  3. bApproximately 1/3 of infected mothers transmit to the fetus. cCost analysis data for Brazil provided by Eleonor G.Lago, MD, PhD
Back to article page